These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 750110)

  • 81. Effect of partition coefficient on the ability of nitroimidazoles to enhance the cytotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Hirst DG; Brown JM; Hazlehurst JL
    Cancer Res; 1983 May; 43(5):1961-5. PubMed ID: 6682009
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).
    Weiss RB; Issell BF
    Cancer Treat Rev; 1982 Dec; 9(4):313-30. PubMed ID: 6762924
    [No Abstract]   [Full Text] [Related]  

  • 83. Physiologic disposition of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (Me CCNU) in man.
    Sponzo RW; DeVita VT; Oliverio VT
    Cancer; 1973 May; 31(5):1154-6. PubMed ID: 4705152
    [No Abstract]   [Full Text] [Related]  

  • 84. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents.
    Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J
    Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Controlled delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymer.
    Yang MB; Tamargo RJ; Brem H
    Cancer Res; 1989 Sep; 49(18):5103-7. PubMed ID: 2766281
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Experiments on the chemotheraphy of a transplantable glioblastoma in the rat, employing 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
    Waldbaur H; Kuschnir H; Engelmann U; Schmidt H; Schmack B
    Acta Neurochir (Wien); 1978; 42(1-2):103-8. PubMed ID: 696438
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Time dependence of the potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity caused by alpha-difluoromethylornithine-induced polyamine depletion in 9L rat brain tumor cells.
    Alhonen-Hongisto L; Deen DF; Marton LJ
    Cancer Res; 1984 May; 44(5):1819-22. PubMed ID: 6424930
    [TBL] [Abstract][Full Text] [Related]  

  • 88. In vitro analysis of BCNU-sensitivity in human malignant gliomas. II. Cross-resistance studies with cisplatinum and nitrosoureas.
    Gerosa MA; Rosenblum ML; Stevanoni G; Licata C; Della Corte V; Marcon C; Bricolo A; Tridente G
    Acta Neurol Scand; 1986 Jan; 73(1):66-70. PubMed ID: 3006422
    [TBL] [Abstract][Full Text] [Related]  

  • 89. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():137-49. PubMed ID: 6944256
    [No Abstract]   [Full Text] [Related]  

  • 90. The effect of amphotericin B on the survival of brain-tumor-bearing mice treated with CCNU.
    Muller PJ; Tator CH
    J Neurosurg; 1978 Oct; 49(4):579-88. PubMed ID: 690687
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea of the EMT6 tumor in vivo as determined by both tumor volume response and in vitro plating assay.
    Twentyman PR
    Cancer Res; 1978 Aug; 38(8):2395-400. PubMed ID: 667838
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.
    Batista LF; Roos WP; Christmann M; Menck CF; Kaina B
    Cancer Res; 2007 Dec; 67(24):11886-95. PubMed ID: 18089819
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Multidisciplinary treatment for central nervous system tumours with nitrosourea compounds.
    Paoletti P; Robustelli della Cuna G; Knerich R; Strada MR
    Acta Neurochir (Wien); 1978; 41(4):287-99. PubMed ID: 356524
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Analysis and distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in biological specimens.
    Hochberg FH; Poletti CE; Krull IS; Strauss J
    Neurosurgery; 1983 Sep; 13(3):230-3. PubMed ID: 6621835
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Evaluation of in vitro and in vivo antitumor activity of BCNU-loaded PLGA wafer against 9L gliosarcoma.
    Lee JS; An TK; Chae GS; Jeong JK; Cho SH; Lee HB; Khang G
    Eur J Pharm Biopharm; 2005 Jan; 59(1):169-75. PubMed ID: 15567315
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The effect of topical CCNU(1-(2-chloroethyl)-3 cyclohexyl 1 nitrosurea) treatment on lipid peroxidation of glial tumours transplanted on rat brain.
    Açikgöz S; Bingol F; offin S; Açikgöz B
    Gen Pharmacol; 1995 Mar; 26(2):437-9. PubMed ID: 7590100
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pharmacokinetics of fotemustine and BCNU in plasma, liver and tumor tissue of rats bearing two lines of Walker 256 carcinoma.
    Guaitani A; Corada M; Lucas C; Lemoine A; Garattini S; Bartosek I
    Cancer Chemother Pharmacol; 1991; 28(4):293-7. PubMed ID: 1879046
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effects of carbamoylating agents on tumor metabolism.
    Lea MA
    Crit Rev Oncol Hematol; 1987; 7(4):329-71. PubMed ID: 3322594
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Response to BCNU of spheroids grown from mixtures of drug-sensitive and drug-resistant cells.
    Tofilon PJ; Arundel CM; Deen DF
    Cancer Chemother Pharmacol; 1987; 20(2):89-95. PubMed ID: 3664937
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance.
    Schepkin VD; Lee KC; Kuszpit K; Muthuswami M; Johnson TD; Chenevert TL; Rehemtulla A; Ross BD
    NMR Biomed; 2006 Dec; 19(8):1035-42. PubMed ID: 16894643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.